ONC included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding ONC
7 latest ETF portfolios currently report this security. This page shows rows 1–7 of 7.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| FBT | First Trust NYSE Arca Biotechnology Index Fund | 3.122138% | 2025-03-31 | 2026-03-31 |
| CANC | Tema Oncology ETF | 1.776504% | 2025-02-28 | 2026-02-28 |
| BBP | Virtus Biotech Etf | 1.476658% | 2025-01-31 | 2026-04-30 |
| LIVR | Intelligent Alpha Atlas ETF | 0.96% | 2026-03-31 | 2026-03-31 |
| HELX | Franklin Genomic Advancements ETF | 0.289395% | 2025-09-30 | 2026-03-31 |
| SPWO | SP Funds S&P World (ex-US) ETF | 0.24315% | Present before retained history; addition date unavailable | 2026-04-30 |
| NTSE | WisdomTree Emerging Markets Efficient Core Fund | 0.17663% | 2025-03-31 | 2026-03-31 |